Diphenhydramine Hcl Oral Solution
Product Images NDC 57237-318

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Hcl Oral Solution (NDC 57237-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diphenhydramine-case-lab (Diphenhydramine Case Lab)

FDA Label Image

Diphenhydramine-lid-lab (Diphenhydramine Lid Lab)

Diphenhydramine-lid-lab (Diphenhydramine Lid Lab)
This is an oral solution of Diphenhydramine HCI, with a concentration of 25 mg per 10 mL. It is intended for institutional use only. The expiration date and lot number are provided. The solution is distributed by Rising Pharma Holdings, Inc. based in East Brunswick, NJ. The product is issued with a label that expires in December 2023 (Iss. 12/2023 FG-36). The identification number provided is 5723731301, and the name of the company associated with the product is PR Rising.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.